-
1
-
-
84867900638
-
Long non-coding RNAs and cancer: A new frontier of translational research?
-
Spizzo R, Almeida MI, Colombatti A, et al. Long non-coding RNAs and cancer: a new frontier of translational research?. Oncogene. 2012;31:4577-4587
-
(2012)
Oncogene
, vol.31
, pp. 4577-4587
-
-
Spizzo, R.1
Almeida, M.I.2
Colombatti, A.3
-
2
-
-
84891898005
-
Long noncoding RNAYmediated intrachromosomal interactions promote imprinting at the Kcnq1 locus
-
Zhang H, Zeitz MJ, Wang H, et al. Long noncoding RNAYmediated intrachromosomal interactions promote imprinting at the Kcnq1 locus. J Cell Biol. 2014;204:61-75
-
(2014)
J Cell Biol
, vol.204
, pp. 61-75
-
-
Zhang, H.1
Zeitz, M.J.2
Wang, H.3
-
3
-
-
46649093597
-
Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription
-
Wang X, Arai S, Song X, et al. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature. 2008;454:126-130
-
(2008)
Nature
, vol.454
, pp. 126-130
-
-
Wang, X.1
Arai, S.2
Song, X.3
-
4
-
-
81055140863
-
LncRNA-and Pc2 methylationYdependent gene relocation between nuclear structures mediates gene activation programs
-
Yang L, Lin C, Liu W, et al. lncRNA-and Pc2 methylationYdependent gene relocation between nuclear structures mediates gene activation programs. Cell. 2011;147:773-788
-
(2011)
Cell
, vol.147
, pp. 773-788
-
-
Yang, L.1
Lin, C.2
Liu, W.3
-
5
-
-
80055046798
-
Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans
-
Yang F, Zhang L, Huo XS, et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology. 2011;54:1679-1689
-
(2011)
Hepatology
, vol.54
, pp. 1679-1689
-
-
Yang, F.1
Zhang, L.2
Huo, X.S.3
-
6
-
-
84892967801
-
Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer
-
Sun M, Xia R, Jin F, et al. Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumour Biol. 2013;35:1065-1073
-
(2013)
Tumour Biol
, vol.35
, pp. 1065-1073
-
-
Sun, M.1
Xia, R.2
Jin, F.3
-
7
-
-
33748675254
-
An RNA gene expressed during cortical development evolved rapidly in humans
-
Pollard KS, Salanma SR, Lambert N, et al. An RNA gene expressed during cortical development evolved rapidly in humans. Nature. 2006;443:167-172
-
(2006)
Nature
, vol.443
, pp. 167-172
-
-
Pollard, K.S.1
Salanma, S.R.2
Lambert, N.3
-
8
-
-
34547515964
-
Dendritie BC200 RNA in aging and in Alzheimer's disease
-
Mus E, Hof PR, Tiedge H. Dendritie BC200 RNA in aging and in Alzheimer's disease. Proc Natl Acad Sci U S A. 2007;104:10679-10684
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 10679-10684
-
-
Mus, E.1
Hof, P.R.2
Tiedge, H.3
-
9
-
-
77951118936
-
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
-
Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464:1071-1076
-
(2010)
Nature
, vol.464
, pp. 1071-1076
-
-
Gupta, R.A.1
Shah, N.2
Wang, K.C.3
-
10
-
-
33846950027
-
A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas
-
Lin R, Maeda S, Liu C, et al. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene. 2007;26:851-858
-
(2007)
Oncogene
, vol.26
, pp. 851-858
-
-
Lin, R.1
Maeda, S.2
Liu, C.3
-
11
-
-
0030031360
-
Loss of H19 imprinting in esophageal cancer
-
Hibi K, Nakamura H, Hirai A, et al. Loss of H19 imprinting in esophageal cancer. Cancer Res. 1996;56:480-482
-
(1996)
Cancer Res
, vol.56
, pp. 480-482
-
-
Hibi, K.1
Nakamura, H.2
Hirai, A.3
-
12
-
-
69849100347
-
Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences
-
Mizrahi A, Czerniak A, Levy T, et al. Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences. J Transl Med. 2009;7:1479-5876
-
(2009)
J Transl Med
, vol.7
, pp. 1479-5876
-
-
Mizrahi, A.1
Czerniak, A.2
Levy, T.3
-
13
-
-
0027442239
-
Tumor-suppressor activity of H19 RNA
-
Hao Y, Crenshaw T, Moulton T, et al. Tumor-suppressor activity of H19 RNA. Nature. 1993;365:764-767
-
(1993)
Nature
, vol.365
, pp. 764-767
-
-
Hao, Y.1
Crenshaw, T.2
Moulton, T.3
-
14
-
-
79956095811
-
Lsinct5 is overexpressed in breast and ovarian cancer and affects cellular proliferation
-
Silva JM, Boczek NJ, Berres MW, et al. LSINCT5 is overexpressed in breast and ovarian cancer and affects cellular proliferation. RNA Biol. 2011;8:496-505
-
(2011)
RNA Biol
, vol.8
, pp. 496-505
-
-
Silva, J.M.1
Boczek, N.J.2
Berres, M.W.3
-
15
-
-
80051574678
-
Expression and function of a large non-coding rna gene xist in human cancer
-
Weakley SM,Wang H, Yao Q, et al. Expression and function of a large non-coding RNA gene XIST in human cancer. World J Surg. 2011;35:1751-1756
-
(2011)
World J Surg
, vol.35
, pp. 1751-1756
-
-
Weakley Smwang, H.1
Yao, Q.2
-
16
-
-
4444381577
-
Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells
-
Kawakami T, Zhang C, Taniguchi T, et al. Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells. Oncogene. 2004;23:6163-6169
-
(2004)
Oncogene
, vol.23
, pp. 6163-6169
-
-
Kawakami, T.1
Zhang, C.2
Taniguchi, T.3
-
18
-
-
0036366478
-
Expression of multidrug resistance-associated markers, their relation to quantitative pathologic tumour characteristics and prognosis in advanced ovarian cancer
-
Brinkhuis M, Izquierdo MA, Baak JP, et al. Expression of multidrug resistance-associated markers, their relation to quantitative pathologic tumour characteristics and prognosis in advanced ovarian cancer. Anal Cell Pathol. 2002;24:17-23
-
(2002)
Anal Cell Pathol
, vol.24
, pp. 17-23
-
-
Brinkhuis, M.1
Izquierdo, M.A.2
Baak, J.P.3
-
19
-
-
0033034825
-
Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer
-
Tanos V, Prus D, Ayesh S, et al. Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol. 1999;85:7-11
-
(1999)
Eur J Obstet Gynecol Reprod Biol
, vol.85
, pp. 7-11
-
-
Tanos, V.1
Prus, D.2
Ayesh, S.3
-
20
-
-
0001363327
-
Sex chromatin and gene action in the mammalian X-chromosome
-
Lyon MF. Sex chromatin and gene action in the mammalian X-chromosome. Am J Hum Genet. 1962;14:135-148
-
(1962)
Am J Hum Genet
, vol.14
, pp. 135-148
-
-
Lyon, M.F.1
-
21
-
-
0037051698
-
Use of H19 regulatory sequences for targeted gene therapy in cancer
-
Ohana P, Bibi O, Matouk I, et al. Use of H19 regulatory sequences for targeted gene therapy in cancer. Int J Cancer. 2001;98:645-650
-
(2001)
Int J Cancer
, vol.98
, pp. 645-650
-
-
Ohana, P.1
Bibi, O.2
Matouk, I.3
-
22
-
-
0036789524
-
Possible physiological role of H19 RNA
-
Ayesh S, Matouk I, Schneider T, et al. Possible physiological role of H19 RNA. Mol Carcinog. 2002;35:63-74
-
(2002)
Mol Carcinog
, vol.35
, pp. 63-74
-
-
Ayesh, S.1
Matouk, I.2
Schneider, T.3
-
23
-
-
0037112364
-
Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2
-
Cui H, Onyango P, Brandenburg S, et al. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res. 2002;62:6442-6446
-
(2002)
Cancer Res
, vol.62
, pp. 6442-6446
-
-
Cui, H.1
Onyango, P.2
Brandenburg, S.3
-
25
-
-
0031053945
-
Genomic imprinting and the endometrial cycle the expression of the imprinted gene H19 in the human female reproductive organs
-
Ariel I, Weinstein D, Voutilainen R, et al. Genomic imprinting and the endometrial cycle. The expression of the imprinted gene H19 in the human female reproductive organs. Diagn Mol Pathol. 1997;6:17-25
-
(1997)
Diagn Mol Pathol
, vol.6
, pp. 17-25
-
-
Ariel, I.1
Weinstein, D.2
Voutilainen, R.3
-
26
-
-
0033012856
-
Quantitation of 4-oxo-4-(3-pyridyl) butanoic acid and enantiomers of 4-hydroxy-4-(3-pyridyl)butanoic acid in human urine: A substantial pathway of nicotine
-
Hecht SS, Hatsukami DK, Bonilla LE, et al. Quantitation of 4-oxo-4-(3-pyridyl) butanoic acid and enantiomers of 4-hydroxy-4-(3-pyridyl)butanoic acid in human urine: a substantial pathway of nicotine. Chem Res Toxicol. 1999;12:172-179
-
(1999)
Chem Res Toxicol
, vol.12
, pp. 172-179
-
-
Hecht, S.S.1
Hatsukami, D.K.2
Bonilla, L.E.3
-
27
-
-
0033535375
-
DNA adduct formation from tobacco-specific N-nitrosamines
-
Hecht SS. DNA adduct formation from tobacco-specific N-nitrosamines. Mutat Res. 1999;424:127-142
-
(1999)
Mutat Res
, vol.424
, pp. 127-142
-
-
Hecht, S.S.1
-
28
-
-
84931565700
-
NNK reduction pathway gene polymorphisms and risk of lung cancer
-
Modesto JL, Hull A, Angstadt AY, et al. NNK reduction pathway gene polymorphisms and risk of lung cancer. Mol Carcinog. 2014;29:22187
-
(2014)
Mol Carcinog
, vol.29
, pp. 22187
-
-
Modesto, J.L.1
Hull, A.2
Angstadt, A.Y.3
-
29
-
-
34547100782
-
Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines
-
Benoit MH, Hudson TJ, Maire G, et al. Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines. Int J Oncol. 2007; 30:5-17
-
(2007)
Int J Oncol
, vol.30
, pp. 5-17
-
-
Benoit, M.H.1
Hudson, T.J.2
Maire, G.3
-
30
-
-
0036691881
-
Relationship of XIST expression and responses of ovarian cancer to chemotherapy
-
Huang KC, Rao PH, Lau CC, et al. Relationship of XIST expression and responses of ovarian cancer to chemotherapy. Mol Cancer Ther. 2002;1:769-776
-
(2002)
Mol Cancer Ther
, vol.1
, pp. 769-776
-
-
Huang, K.C.1
Rao, P.H.2
Lau, C.C.3
|